Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam besylate combined with propofol for ERCP anesthesia
ChiCTR2300073982Phase 4Not yet recruiting
- Sponsor
- Shifang People's Hospital
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in choledocholithiasis comparing Remimazolam + propofol with Placebo + propofol (2 arms). Primary endpoints: Prostaglandin 2, Interleukin-17 and 2 more. Planned start Jul 2023; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
choledocholithiasis
Beyond the preview
Go deeper on ChiCTR2300073982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300073982.